CARDIOMYOCYTES: THE HEART'S ESSENTIAL CELLS

Cardiomyocytes, the specialized muscle cells of the heart, are responsible for the contractile function that enables blood circulation throughout the body. These cells possess unique structural and functional properties, including the ability to generate electrical impulses and synchronize contractions. Understanding cardiomyocytes is essential for studying cardiac function and diseases such as arrhythmias, cardiomyopathies, and heart failure.

At AnyGenes, we provide cutting-edge tools to support cardiomyocyte research. Our high-quality qPCR arrays and molecular biology reagents are tailored to analyze the expression of genes involved in cardiomyocyte function, growth, and stress responses. These solutions are designed for precision, helping researchers uncover insights into cardiac development, disease mechanisms, and potential therapies.

Cardiomyocytes signaling pathways qPCR array by AnyGenes for advanced cardiac research.

Discover our advanced qPCR arrays for Cardiomyocytes Pathway research.

cardiomyocytes and Excitation–contraction coupling (ECC) process

Excitation–contraction coupling (ECC). (1) An action potential depolarizes the cardiomyocyte and induces Na+ influx through voltage-gated Na+ channels (Nav). (2) This further depolarizes the cell membrane and induces Ca2+ influx through voltage-gated L-type Ca2+ channels (LTCCs). (3) This Ca2+ entry stimulates Ca2+ release via dyadic RyR2 on the SR (4), which in turn triggers cell contraction through activating myofilament crossbridges.

(5) LTCC inactivate and RyR close. (6) Cytosolic Ca2+ is then moved out of the cell by the Na+/Ca2+ exchanger (NCX) and pumped back into the SR by SERCA2a, thereby decreasing cytosolic Ca2+ concentration and bringing about relaxation. (7) A family of K+ channels participate in cell repolarization with K+ efflux as a last step for returning membrane potential to its resting value before a new cycle starts. (8) Tuning ECC to meet cardiovascular demands involves β-adrenergic pathways that induce the activation of CaMKII and of cAMP/PKA, which phosphorylates voltage-gated LTCCs and RyRs to enhance their activity and phospholamban (PLB) to remove its inhibition of SERCA activity.

KEY CARDIOMYOCYTES SIGNALING PATHWAYS

Cardiomyocytes, the heart's muscle cells, rely on intricate signaling pathways to regulate their contraction, growth, and response to stress. These pathways are essential for maintaining the heart’s rhythm, adapting to physiological demands, and protecting against damage.

Calcium Signaling: Calcium ions play a pivotal role in cardiomyocyte contraction and relaxation.
PI3K-Akt Pathway: The PI3K-Akt signaling pathway promotes cardiomyocyte survival and growth by protecting against stress-induced apoptosis.
MAPK Pathways: Mitogen-activated protein kinase (MAPK) pathways, including ERK, JNK, and p38 MAPK, are involved in the cellular responses to stress, hypertrophy, and remodeling.
Beta-Adrenergic Signaling: This pathway regulates heart rate and contractility in response to stress or exercise.
Wnt/β-Catenin Pathway: This signaling pathway is involved in cardiomyocyte development and regeneration. It also plays a role in cardiac fibrosis, a common feature of heart disease.

CHALLENGE IN CARDIOMYOCYTE RESEARCH

Researching cardiomyocytes presents unique challenges due to their complex structure and limited regenerative capacity. Unlike other cell types, cardiomyocytes have a highly specialized function and depend on finely tuned signaling networks to maintain cardiac output. These challenges include:

Limited Proliferation: Cardiomyocytes rarely divide, making it difficult to study their regeneration and repair mechanisms.
Sensitivity to Stress: They are highly susceptible to oxidative stress, hypoxia, and mechanical strain.
Intricate Signaling: Understanding their signaling pathways requires precise tools and methods due to their complexity and interconnectivity.

Advanced molecular biology tools, like qPCR arrays, help overcome these challenges by enabling precise gene expression analysis in cardiomyocyte studies.

APPLICATION OF CARDIOMYOCYTE RESEARCH

Cardiomyocyte research is essential for a variety of scientific and medical advancements:

Drug Discovery: Testing new drugs for their effects on cardiomyocyte function, such as contractility, metabolism, and survival.
Disease Modeling: Understanding genetic and molecular mechanisms in conditions like hypertrophic cardiomyopathy, heart failure, and ischemic injury.
Regenerative Medicine: Exploring stem cell therapies and gene editing technologies to regenerate damaged cardiac tissues.
Toxicology Studies: Assessing the cardiotoxicity of pharmaceuticals or environmental toxins.

AnyGenes’ qPCR arrays and molecular tools support these applications, ensuring researchers have the precision needed for reliable and reproducible results.

CARDIOMYOCYTES IN DISEASES

Cardiomyocytes are central to many cardiovascular and systemic diseases, with dysfunction leading to conditions like heart failure, cardiomyopathies, and ischemic heart disease.

Heart Failure: Caused by hypertrophy, oxidative stress, and calcium signaling abnormalities that impair contractile function.
Ischemic Heart Disease: Oxygen deprivation leads to cardiomyocyte death, scarring, and reduced heart function.
Cardiomyopathies: Includes dilated, hypertrophic, and restrictive cardiomyopathies, often linked to genetic mutations or stress.
Metabolic Disorders: Diabetes and obesity disrupt cardiomyocyte metabolism, increasing vulnerability to heart diseases.
Cardiotoxicity: Certain drugs, like chemotherapy agents, damage cardiomyocytes, resulting in drug-induced cardiomyopathy.

(1) Judina A, Gorelik J, Wright PT. Studying signal compartmentation in adult cardiomyocytes. Biochem Soc Trans. (2020);48(1):61-70.

(2) Gilbert G, et al. Calcium Signaling in Cardiomyocyte Function. Cold Spring Harb Perspect Biol. (2020);12(3):a035428.

(3) Zhang G, et al. Cardiomyocyte death in sepsis: Mechanisms and regulation (Review). Mol Med Rep. (2022);26(2):257.

(4) Duong MN et al. The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance. Oncotarget. (2017).

(5) Choi J et al. Adipocyte biology in breast cancer: From silent bystander to active facilitator. Prog Lipid Res. (2018);(69):11-20.

CARDIOMYOCYTES SIGNALING PATHWAY BIOMARKER LIST

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to get started on your project.

You can check the biomarker list included in this pathway, see below:

Species : Homo sapiens (human)

Signaling Pathways	Product ref	Informations
Cardiomyocytes Signaling Pathway	CMC1H1	List infos

Species : Mus musculus (mouse)

Signaling Pathways	Product ref	Informations
Cardiomyocytes Signaling Pathway	CMC1M1	List infos

Species : Rattus norvegicus (rat)

Signaling Pathways	Product ref	Informations
Cardiomyocytes Signaling Pathway	*******	List In progress...

Species : Sus Scrofa (Pig)

Signaling Pathways	Product ref	Informations
Cardiomyocytes Signaling Pathway	*******	List In progress...

For more information on prices, please click here